As of June 2026, 1 paid clinical trial is recruiting for Idiopathic pulmonary fibrosis in Iowa City, Iowa. Recruiting Idiopathic pulmonary fibrosis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Iowa City has approximately 592 recruiting research studies across a wide range of therapeutic areas. Iowa hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Researchers run research studies in Iowa City, IA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Iowa | Hearing Loss, Sensorineural, Cystic Fibrosis, Gestational Diabetes | 196 |
| University of Iowa/Holden Comprehensive Cancer Center | Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy, B Acute Lymphoblastic Leukemia | 74 |
| University of Iowa Hospitals and Clinics | Atrial Fibrillation, Carrier State, Extensive Stage Small Cell Lung Cancer | 63 |
| University of Iowa Health Care | COVID-19, Major Depression, Supraventricular Tachycardia (SVT) | 40 |
| University of Iowa Hospitals & Clinics | AML With Mutated NPM1, Acute Myeloid Leukemia, Hematologic Malignancy | 23 |
| University of Iowa Hospital and Clinics | Multiple Myeloma, Ovarian Cancer, Anesthesia | 12 |
| University of Iowa Stead Family Children's Hospital | Acute Myeloid Leukemia, Adrenal Insufficiency, Anesthesia | 8 |
| Iowa City VA Health Care System, Iowa City, IA | Chronic Kidney Disease, Atherosclerosis, End-Stage Kidney Disease | 5 |
| The University of Iowa | Immune Thrombocytopenic Purpura (ITP), Abdominal Abscess, Attention Deficit Disorder With Hyperactivity (ADHD) | 5 |
| University of Iowa Children's Hospital | Atrial Arrhythmia, Atrial Tachycardia, Congenital Heart Disease | 4 |
| University of Iowa Hospital | Acute Kidney Injury, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia | 4 |
| Clinical Trial Site | ATTR Amyloidosis, Generalized Myasthenia Gravis, Hereditary Transthyretin-mediated (hATTR) Amyloidosis | 3 |
| Holden Comprehensive Cancer Center | Astrocytoma, IDH-Mutant, Grade 4, Diffuse Hemispheric Glioma, H3 G34-Mutant, Diffuse Midline Glioma (DMG) | 3 |
| Integrative Laboratory of Applied Physiology and Lifestyle Medicine | Adverse Childhood Experiences, Endothelial Dysfunction, Oxidative Stress | 3 |
| University of Iowa Carver College of Medicine | Delirium, Depression, Early Onset Hereditary Spastic Paraplegia | 3 |
| University of Iowa Healthcare | Cardiovascular Diseases, Cochlear Implantation, Cognitive Impairment, Mild | 3 |
| University of Iowa- Site Number : 840032 | Cerebroside Lipidosis Syndrome, Fabry Disease, Gaucher Disease | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Ascendis Investigational Site | Growth Hormone Deficiency | 2 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Neoplasms, Head and Neck | 2 |
| Holden Comprehensive Cancer Center at the University of Iowa | B Cell Lymphoma, B Cell Non-Hodgkin's Lymphoma, Lymphoma | 2 |
| Iowa Bioscience Innovation Facility | Electronic Cigarette Use, Endothelial Dysfunction, Gestational Diabetes Mellitus (GDM) | 2 |
| Iowa City VA Healthcare System | Previously Treated Non-Small Cell Lung Cancer, Tobacco Cessation | 2 |
| Research Facility | Carcinoid, Carcinoid Tumor, GEP-NET | 2 |
| Stead Family Children's Hospital | Cardiac Arrest (CA), Deep Venous Thrombosis | 2 |
Recruiting trials in Iowa City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Iowa are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Iowa research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in Iowa City from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 592 recruiting clinical trials in Iowa City, Iowa listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Iowa City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Iowa City include Acute Myeloid Leukemia (11), Breast Cancer (10), Multiple Myeloma (8), Hearing Loss, Sensorineural (6), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Iowa City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Iowa City include University of Iowa, University of Iowa/Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Iowa City are Cancer & tumors (183), Neurology & pain (38), Cardiovascular (30). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.